Tumor Lysis Syndrome in a Patient With Gastric Adenocarcinoma by Prasanth Lingamaneni MD, Parth Desai MD, Madhu Mathew Vennikandam MD, Krishna Moturi MD, Anmol Baranwal MD, Shweta Gupta MD

Get full text

P1346: THE IMPACT OF CYTOTOXIC THERAPY ON THE RISK OF PROGRESSION AND DEATH IN PATIENTS WITH CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE. by LI Marissa, Anmol Baranwal, Syed Shah, Mark Gurney, Al-Kali Aref, Alkhateeb Hassan, Foran James, Cecilia Arana Yi, Dong Chen, Abhishek Mangaonkar, Kristen Mccoullough, Ayalew Tefferi, Mrinal Patnaik, Mithun Shah

Get full text

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE by Rami Basmaci, Anmol Baranwal, Rong He, David Viswanatha, Patricia Greipp, James M Foran, Cecilia Arana Yi, Mithun Shah, Abhishek Mangaonkar, Mark Litzow, William Hogan, Kebede Benga, Antoine Saliba, Naseema Gangat, Ayalew Tefferi, Mrinal Patnaik, Aref Al-Kali, Hassan Alkhateeb

Get full text

Genetic landscape and clinical outcomes of patients with <i>BCOR</i> mutated myeloid neoplasms by Anmol Baranwal, Mark Gurney, Rami Basmaci, Bahga Katamesh, Rong He, David S. Viswanatha, Patricia Greipp, James Foran, Talha Badar, Hemant Murthy, Cecilia Arana Yi, Jeanne Palmer, Abhishek A. Mangaonkar, Mrinal M. Patnaik, Mark R. Litzow, William J. Hogan, Kebede Begna, Naseema Gangat, Ayalew Tefferi, Aref Al-Kali, Mithun V. Shah, Hassan B. Alkhateeb

Get full text

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms by Mithun Vinod Shah, Elizabeth Ngoc Hoa Tran, Syed Shah, Rakchha Chhetri, Anmol Baranwal, Dariusz Ladon, Carl Shultz, Aref Al-Kali, Anna L. Brown, Dong Chen, Hamish S. Scott, Patricia Greipp, Daniel Thomas, Hassan B. Alkhateeb, Deepak Singhal, Naseema Gangat, Sharad Kumar, Mrinal M. Patnaik, Christopher N. Hahn, Chung Hoow Kok, Ayalew Tefferi, Devendra K. Hiwase

Get full text